Respigam

DB17765Investigational

Respigam: Overview.

First approval
Canada, 1997
Also known as
RSV-IGIV
Code names
RI-002

Resolves to

Clinical / RWD

What you can answer from here — as of April 23, 2025

1Clinical trialPhase, status and sponsor resolved per trial
Sign in
3Marketed productsAcross 1 country and 1 labeller
Sign in

Which companies are running trials of Respigam, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.

Create Account